Emerging molecular markers of cancer

David Sidransky

doi:10.1038/nrc755

Emerging molecular markers of cancer

David Sidransky

School of Medicine

Research output: Contribution to journal › Review article › peer-review

534 Scopus citations

Abstract

Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. These 'molecular markers' can be useful in detecting cancer, determining prognosis and monitoring disease progression or therapeutic response. But what is the best way to identify molecular markers and can they be easily incorporated into the clinical setting?

Original language	English (US)
Pages (from-to)	210-219
Number of pages	10
Journal	Nature Reviews Cancer
Volume	2
Issue number	3
DOIs	https://doi.org/10.1038/nrc755
State	Published - Mar 2002

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1038/nrc755

Cite this

@article{53e8bb27be024fb5a6e82918a837a2fb,

title = "Emerging molecular markers of cancer",

abstract = "Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. These 'molecular markers' can be useful in detecting cancer, determining prognosis and monitoring disease progression or therapeutic response. But what is the best way to identify molecular markers and can they be easily incorporated into the clinical setting?",

author = "David Sidransky",

note = "Funding Information: The author would like to thank S. M. Hanash and G. W. Hart for their critical review. Supported by a National Institute of Health grant, as part of the Early Detection Research Network.",

year = "2002",

month = mar,

doi = "10.1038/nrc755",

language = "English (US)",

volume = "2",

pages = "210--219",

journal = "Nature Reviews Cancer",

issn = "1474-175X",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Emerging molecular markers of cancer

AU - Sidransky, David

N1 - Funding Information: The author would like to thank S. M. Hanash and G. W. Hart for their critical review. Supported by a National Institute of Health grant, as part of the Early Detection Research Network.

PY - 2002/3

Y1 - 2002/3

N2 - Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. These 'molecular markers' can be useful in detecting cancer, determining prognosis and monitoring disease progression or therapeutic response. But what is the best way to identify molecular markers and can they be easily incorporated into the clinical setting?

AB - Alterations in gene sequences, expression levels and protein structure or function have been associated with every type of cancer. These 'molecular markers' can be useful in detecting cancer, determining prognosis and monitoring disease progression or therapeutic response. But what is the best way to identify molecular markers and can they be easily incorporated into the clinical setting?

UR - http://www.scopus.com/inward/record.url?scp=0036515416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036515416&partnerID=8YFLogxK

U2 - 10.1038/nrc755

DO - 10.1038/nrc755

M3 - Review article

C2 - 11990857

AN - SCOPUS:0036515416

SN - 1474-175X

VL - 2

SP - 210

EP - 219

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

IS - 3

ER -

Emerging molecular markers of cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this